Farxiga alternative?

What are the alternative treatments to Farxiga for diabetic patients?

Farxiga (dapagliflozin) is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used to treat type 2 diabetes and chronic kidney disease (CKD) in adults [1]. While Farxiga has shown promising results in clinical trials, patients may still seek alternative treatments due to various reasons such as side effects, cost, or insurance coverage. Here are some alternative treatments to Farxiga:

Other SGLT2 inhibitors:

* Jardiance (empagliflozin): Another SGLT2 inhibitor approved for the treatment of type 2 diabetes and CKD in adults [2].
* Invokana (canagliflozin): An SGLT2 inhibitor used to treat type 2 diabetes and CKD in adults [3].

GLP-1 receptor agonists:

* Trulicity (dulaglutide): A glucagon-like peptide-1 (GLP-1) receptor agonist approved for the treatment of type 2 diabetes [4].
* Bydureon (exenatide): A GLP-1 receptor agonist used to treat type 2 diabetes [5].

Metformin-based combinations:

* Omnipod (insulin pump and rapid-acting insulin): A combination therapy that includes metformin and rapid-acting insulin to treat type 2 diabetes [6].
* Victoza (liraglutide): A GLP-1 receptor agonist used in combination with metformin to treat type 2 diabetes [7].

Patent expiry and biosimilars:

* Farxiga's patent is scheduled to expire in 2026 (DrugPatentWatch.com) [8].
* Biosimilar versions of Farxiga may enter the market, which could offer a more cost-effective alternative treatment option.

Regulatory considerations:

* Alternative treatments may have different regulatory approvals or indications, so it's essential to consult with a healthcare provider before switching medications.
* Patients should also be aware of any potential drug interactions, side effects, or contraindications with alternative treatments.

Sources:

[1] Farxiga Prescribing Information.

[2] Jardiance Prescribing Information.

[3] Invokana Prescribing Information.

[4] Trulicity Prescribing Information.

[5] Bydureon Prescribing Information.

[6] Omnipod Prescribing Information.

[7] Victoza Prescribing Information.

[8] DrugPatentWatch.com. Dapagliflozin Patent Expiration.